Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | DGKA | P23743 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | PAM | P19021 | 2/20 | 0.47 |
| ▸ | MGAM | O43451 | 1/20 | 0.46 |
| ▸ | SI | P14410 | 1/20 | 0.46 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.46 |
| ▸ | PGR | P06401 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25823863 | 1.00 | CYP1A2 (0.57) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL8233910 | 1.00 | CYP1A2 (0.57) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL12252302 | 0.98 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL10167892 | 0.91 | — | — | |
| SCHEMBL494584 | 0.89 | CYP1A2 (0.70) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL33870 | 0.89 | CYP1A2 (0.70) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL440349 | 0.89 | CYP1A2 (0.70) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL6055406 | 0.89 | CYP1A2 (0.70) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| Diethyl Octadecanedioate SCHEMBL496152 | 0.89 | CYP1A2 (0.70) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL495925 | 0.89 | CYP1A2 (0.70) | CYP1A2DGKAALDH1A1ALOX15TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7910618-B2 | Polyethylene glycol end-modified by an antibody or maleimide group on one end and a hydroxy fatty acid on the other; increased in vivo half life of insulin; antidiabetic agents | UCB PHARMA S.A. (BE) | 2011-03-22 | — | — | US | disclosed |
| US-20080096957-A1 | Albumin-Binding Conjugates Comprising a Fatty Acid and Peg | CELLTECH R&D LIMITED (GB) | 2008-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080096957-A1 | Albumin-Binding Conjugates Comprising a Fatty Acid and Peg | FABP1, FABP2, FABP4 | CYP1A2 2297/4885DGKA 819/4885ALDH1A1 646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.